LIVER REGENERATION IS A COMPLEX process of tissue repair following assorted chemical toxin-induced acute or chronic liver injury or loss of tissue, such as partial hepatectomy (24) . Mature hepatocytes have the capacity to proliferate after liver injury. This regenerative response involves a large number of soluble cytokines and growth factors, such as IL-6 (35, 38) , tumor necrosis factor (TNF) (32, 43) , hepatocyte growth factor (14) , and IL-22 (29) . In mouse and human liver, an enrichment of cells of the innate immune system, namely, the natural killer (NK) cells and natural killer T (NKT) cells that constitute the dominant intrahepatic lymphocyte population, is observed (10) . Recent research has shown that the innate immune system plays important roles in regulating liver regeneration after partial hepatectomy (7) . During liver regeneration after partial hepatectomy, hepatic NK cells exert negatively modulated effect on regeneration, after being activated by polyinosinicpolycytidylic acid (poly I:C) or murine cytomegalovirus virus (MCMV) infection (34) . The negative effect of NK cells on liver regeneration is likely mediated via the production of IFN-␥ that subsequently activates signal transducer and activator of transcription (STAT) 1 to suppress STAT3, a critical signaling pathway for liver regeneration (11, 34, 36, 41) . NKT cells are a subset of T cells that express both NK and T cell markers. The reports on the role of NKT cells in liver regeneration have been controversial. We have reported that liver regeneration was comparable between NKT-deficient mice and wild-type controls after partial hepatectomy, suggesting that NKT cells may play a minor role in liver regeneration under normal condition in this partial hepatectomy model (34) . NKT cells may play an important role in inhibiting liver regeneration in concanavalin A-induced T cell hepatitis model or in hepatitis B virus transgenic mice (8, 13) . However, it was also reported that injection of NKT cell activator ␣-Galcer enhances hepatocyte proliferation and liver regeneration after partial hepatectomy via TNF-␣ and Fas/Fas-ligandmediated pathways (26) .
To further understand the role of NK cells in liver regeneration, we adopted carbon tetrachloride (CCl 4 )-induced liver injury as a regeneration model to study the role of NK cells in toxin-induced liver regeneration. CCl 4 is the classical hepatotoxin and induces liver injury by altering the permeability of cellular, lysosomal, and mitochondrial membranes to generate free radicals and release large amounts of TNF-␣ (20) . This form of acute liver injury is characterized by centrilobular necrosis, followed by complete regeneration and repair. The mechanisms that are responsible for the recovery of original liver function have not been fully analyzed to date. However, regenerative response may be essential to restore the liver function. By using this CCl 4 -induced liver injury and regeneration model, here we demonstrated that activation of NK cells by poly I:C injection also negatively modulates liver regeneration, which may be mediated via production of high levels of TNF-␣ that inhibits hepatocyte proliferation.
MATERIALS AND METHODS
Mice. Male C57BL/6 mice (6 -8 wk old) were obtained from Experimental Animal Center, Chinese Academy of Sciences (Shanghai, China) and maintained at an animal facility under specific pathogen-free conditions. Experimental procedures were conducted in accordance with the guidelines outlined in the Guide for the Care and Use of Laboratory Animals and approved by the University of Technology and Science of China Animal Care and Committee.
Reagents. Poly I:C (Amersham Pharmacia Biotech, Piscataway, NJ) was dissolved in the pyrogen-free PBS at the concentration of 1 mg/ml and intravenously injected into mice at the indicated dose (1 g/g body wt). To induce liver injury, mice were injected intravenously with poly I:C (1 g/g body wt) and intraperitoneally with CCl 4 (10% in olive oil, 1 ml/kg body wt) (Sigma Chemical, St. Louis, MO), simultaneously. FITC-conjugated anti-NK1.1, PEconjugated anti-IFN-␥, anti-TNF-␣, anti-CD69, and anti-NKG2D; PE-CY5-conjugated anti-CD3e antibodies were purchased from eBioscience (San Diego, CA).
Serum ALT/AST measurements. Serum samples from individual mice were obtained at different time points. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured using commercial available kits (Rong Sheng, Shanghai, China).
Flow cytometry analysis. Hepatic mononuclear cells were prepared as described previously (42) . After blocking with anti-Fc receptor (FcR), cells were incubated with the indicated fluorescence-labeled monoclonal antibodies (mAbs) in the dark at 4°C for 30 min and then washed twice with PBS. The stained cells were analyzed using a flow cytometer (FACScalibur; Becton Dickinson, Franklin Lakes, NJ). For the intracellular cytokine assay, cells were cultured with PMA (30 ng/ml; BD Pharmingen, San Diego, CA) and ionomycin (1 g/ml; Calbiochem, Darmstadt, Germany). After 1 h, monensin (10 g/ml, Sigma) was added to prevent the secretion of the induced cytokines into the supernatant, and the cells were incubated for an additional 5 h in humidified 5% CO 2 at 37°C. After being blocked with anti-FcR, the hepatic mononuclear cells were stained in darkness at 4°C for 30 min with the indicated mAbs FITC-conjugated anti-NK1.1 and PE-CY5-conjugated anti-CD3e for the surface antigens and were subsequently fixed and permeabilized using the Fix/Perm cell permeabilization kit (BD Biosciences, San Jose, CA) for 20 min at room temperature. Then, the cells were stained with PE-conjugated anti-IFN-␥ mAb or PE-conjugated anti-TNF-␣ mAb, washed thrice, and analyzed using flow cytometry.
Cell depletion. To deplete NK cells, mice were injected with 50 g of anti-AsGM1 antibody (Wako, Tokyo, Japan) or 200 g of anti-NK1.1 mAb PK136, 24 h before the experiment. To deplete the Kupffer cells, mice were injected with 100 l of clodronate liposome (Cl2MBP) (Vrije Universiteit, Amsterdam, The Netherlands) 48 h before the experiment, as described previously (40) . To deplete CD4 ϩ , anti-CD4 mAb (100 g, GK1.5; eBioscience, San Diego, CA) was intravenously injected into mice 1 day before the operation. The absence of respective cells was confirmed by flow cytometry.
Determination of liver regeneration. To determine liver regeneration, mice were given an intraperitoneal injection of bromodeoxyuridine (BrdU) (50 mg/kg body wt) 2 h before euthanasia. Liver tissues were harvested and fixed. Sections from formalin fixed and paraffin embedded liver tissue were stained with mouse monoclonal anti-BrdU antibody (Sigma) or rabbit monoclonal anti-Ki67 (Abcam, Cambridge, UK), overnight at 4°C. The ImmPRES anti-mouse Ig or anti-rabbit Ig (Vector Laboratories, Burlingame, CA) was incubated at room temperature for 30 min and then stained with peroxidase substrate 3,3=-diaminobenzidine chromogen (Vector Laboratories) and finally counterstained with hematoxylin. BrdU incorporation and Ki67 staining was determined by counting the positively stained hepatocyte nuclei in 10 microscope fields (ϫ200).
ELISA for TNF-␣ and IFN-␥. Commercially available ELISA kits from R&D systems (Minneapolis, MN) were used to measure serum cytokine levels. The thresholds of detection were 2 pg/ml and 5.1 pg/ml for IFN-␥ and TNF-a, respectively.
Cytokine neutralization. Anti-IFN-␥ neutralizing mAb (R4 -6A2, IgG1) was purified from the hybridoma culture supernatant through ammonium sulfate precipitation obtained from American Type Culture Collection (Manassas, VA). Anti-TNF neutralizing mAb (MP6-XT3, IgG1) was purchased from BD Pharmingen. Mice were intraperitoneally administered with anti-IFN-␥ mAb or anti-TNF mAb (100 g/mouse). Twenty-four or two hours later, poly I:C and CCl4 were injected, respectively. In control mice, IgG1 (BD Pharmingen) was injected at equivalent doses.
Western blotting. Liver tissue samples harvested from the indicated mice at different time points were homogenized in cell lysis buffer containing 1 mM PMSF and a cocktail of protease inhibitors (Roche Molecular Biochemicals, Indianapolis, IN) on ice. After determination of protein concentration using the Bio-Rad Bradford protein assay (Bio-Rad Laboratories, Hercules, CA), 30 g of total protein was loaded on a SDS-PAGE and transferred to PVDF membranes (Millipore, Billerica, MA). After blocking with 5% nonfat milk, membranes were incubated with primary Abs overnight at 4°C, then washed with 0.1% (vol/vol) Tween 20 in TBS (pH 7.6) and incubated with a horseradish peroxidase-conjugated secondary Ab for 60 min at room temperature. Protein bands were visualized by enhanced chemiluminescence reaction (Pierce, Rockford, IL).
Real-time polymerase chain reaction. Total RNA (5 g) was extracted from liver tissue by using Trizol Reagent (Invitrogen, Hercules, CA) and was used for complementary DNA (cDNA) synthesis. Quantitative PCR was conducted via a sequence detector (ABI-Prism 7000; Applied Biosystems, Foster City, CA) with a SYBR Premix Ex Taq (Takara, Madison, WI), according to the manufacturer's instructions. The primer sequences used were as follows: ␤-actin: sense, 5=-CAC AGC TTC TTT GCA GCT CCT T-3=, antisense, 5=-ATG CCG GAG CCG TTG TC-3=; IL-6: sense, 5=-AGA CTT CCA TCC AGT TGC CTT-3=, antisense, 5=-TCT CAT TTC CAC GAT TTC CC-3=; IL-15: sense, 5=-CCA ACT GGA TAG ATG TAA GAT A-3=, antisense, 5=-GTC AGG ACG TGT TGA TGA ACA T-3=; transforming growth factor (TGF)-␤: sense, 5=-GTA CAG CAA GGT CCT TGC CCT-3=, antisense, 5=-TAG TAG ACG ATG GGC AGT GGC-3=; Rae1: sense, 5=-GCT GTT GCC ACA GTC ACA TC-3=; antisense, 5=-CCT GGG TCA CCT GAA GTC AT-3=.
Expression levels of target genes were first normalized to the housekeeping gene ␤-actin (⌬Ct); then gene expression values were calculated on the basis of the ⌬⌬Ct method as mentioned before (46) , using the mean of the respective cytokines in mock-treated mice (0 h) as a calibrator. Relative quantities (RQs) were determined using the following equation: RQ ϭ 2
Ϫ⌬⌬Ct . Hematoxylin-eosin staining. Liver tissues were fixed in 10% buffered formalin and then embedded in paraffin. Five-micron sections were affixed to slides, deparaffinized, and stained with hematoxylin and eosin (H-E) to determine morphological changes.
Statistical analysis. Data are expressed as means Ϯ SE. The differences between the groups were analyzed using Student's t-test, and P Ͻ 0.05 was considered as statistically significant.
RESULTS

Poly I:C injection impairs liver regeneration in CCl 4 -treated mice.
Previously, we showed that poly I:C injection induced activation of hepatic NK cells to produce IFN-␥ and inhibited liver regeneration after partial hepatectomy (34) . CCl 4 -induced liver injury has been suggested to trigger the transition of hepatocytes into the cell cycle and then initiate liver regeneration. Thus we wondered whether poly I:C also has an inhibitory effect on liver regeneration of CCl 4 -treated mice. To answer this question, mice were treated with poly I:C, CCl 4 , or poly I:C plus CCl 4 . As illustrated in Fig. 1A , serum levels of ALT/AST were significantly higher in poly I:C/CCl 4 group than CCl 4 group 12 h and 24 h postinjection. However, serum ALT levels were lower in poly I:C/CCl 4 group than CCl 4 group 48 h postinjection. Poly I:C injection alone only induced mild elevation of serum ALT/AST. Liver histology showed that the amount of hepatocyte necrosis was higher in poly I:C/CCl 4 group than in CCl 4 alone group 48 h postinjection (data not shown). No obvious necrosis was seen in poly I:C alone group. After various time periods postinjection, hepatocyte DNA synthesis was monitored by immunohistochemical staining for BrdU and Ki67 incorporation. As illustrated in Fig. 1 , B-E, BrdU ϩ hepatocytes and Ki67 ϩ hepatocytes were barely detected at 12 h, 24 h, and 7 days after injection in all groups. At 48 h after CCl 4 injection, the number of BrdU-positive hepatocytes/field and Ki67-positive hepatocytes/field in CCl 4 -injected mice was significantly higher than those in poly I:C/CCl 4 coinjected mice or in poly I:C alone group. Consistent with these findings, expression of cyclin D1 and cyclin A, two important markers of cell cycle, was suppressed in poly I:C/CCl 4 -coinjected mice compared with CCl 4 -treated mice alone (Fig. 1F) . We also analyzed cholangiocyte proliferation by counting BrdU-or Ki67-positive cells under high magnification (ϫ400). No obvious cholangiocyte proliferation was observed at 12 h, 24 h, 48 h, and 7 days after CCl 4 or poly I:C/CCl 4 treatment. This may be because the peak of cholangiocyte proliferation occurs at 60 -72 h after CCl 4 treatment.
Poly I:C inhibits CCl 4 -induced liver regeneration via an NK cell-dependent manner. The above data show that poly I:C is able to inhibit liver regeneration in CCl 4 -treated mice. Next we Fig. 1 . Polyinosinic-polycytidylic acid (poly I:C) inhibits liver regeneration in carbon tetrachloride (CCl4)-induced liver injury model. C57BL/6 mice were injected with poly I:C or CCl4, or combination. After various time points, hepatocyte DNA synthesis was monitored by bromodeoxyuridine (BrdU) labeling and Ki67 staining assay. A: time course of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels was measured following injected with poly I:C (1 g/g wt mouse) alone, CCl4 (1 l/g wt mouse) alone, or poly I:C/CCl4 was analyzed. The graph shows the results of one representative experiment with 4 mice per group; values are shown as means Ϯ SE, *P Ͻ 0.05, **P Ͻ 0.01 compared with the poly I:C/CCl4-treated group. B: representative photograph for anti-BrdU immunohistochemical staining of liver sections was obtained at 12 h, 24 h, 48 h, and 7 days after injection was measured (ϫ200). C: graphic representation of the number of BrdU-labeled hepatocytes/field (ϫ200). Values are shown as means Ϯ SE from 4 mice. *P Ͻ 0.05 compared with the CCl4-treated group. D: representative photograph for Ki67 immunohistochemical staining of liver sections was obtained at 24 h, 48 h, and 7 days after injection was measured (ϫ200). E: graphic representation of the number of Ki67-labeled hepatocytes/field (ϫ200). Values are shown as means Ϯ SE from 4 mice. *P Ͻ 0.05 compared with the CCl4-treated group. F: liver tissues from the mice injected with CCl4 alone, or poly I:C/ CCl4 coinjected at the different time points were subjected to Western blotting analyses of expression of cyclins (cyclin D1 and cyclin A). examined whether poly I:C recruited and activated NK cells in CCl 4 -treated mice. As shown in Fig. 2, A and B, administration of CCl 4 alone or poly I:C alone slightly increased the number of NK cells (CD3 Ϫ NK1.1 ϩ ) in the liver, while coadministration of CCl 4 plus poly I:C promoted the significant accumulation of liver NK cells, with the peak effect at 24 h postinjection. According to previous study, we believe that such accumulation is attributable to the result of recruitment of NK cells from the spleen (6). From Fig. 3A , we found that at 0 h, CD3 Ϫ NK1.1 ϩ NK cells express at high levels of CD69 (40%), indicating that NK cells in the normal liver are activated. NK cells were slightly activated after CCl 4 alone treatment as shown by elevated expression of CD69 but were markedly activated after poly I:C or poly I:C plus CCl 4 injection (Fig.  3A) . The expression levels of NKG2D on NK cells were upregulated in all of these three groups with different extents (Fig. 3B) , whereas expression of Ly49A, Ly49C/I/F/H, and NKG2A/C/E on NK cells were similar between CCl 4 and poly I:C/CCl 4 group (data not shown). Expression of the ligands of NKG2D, Rae1 in the liver is significantly higher in poly I:C/CCl 4 -coinjected mice than in CCl 4 -injected mice alone after 48-h treatment (Supplemental Fig. S1 ; supplemental material for this article is available online at the American Journal of Physiology Gastrointestinal and Liver Physiology website).
It was reported that the cytokine TGF-␤ could downregulate, while IL-15 could enhance, NKG2D expression (21, 30) . Furthermore, IL-6 is an important component of the early signaling pathways leading to regeneration. Therefore, we examined the expression of these cytokines in the liver by real-time PCR. There were no significant differences in these cytokines TGF-␤, IL-15, and IL-6 messenger RNA (mRNA) levels in liver tissue after poly I:C/CCl 4 or CCl 4 administration alone (Fig. 3C) .
To further determine the role of NK cells in CCl 4 -induced liver regeneration, mice were intravenously injected with antiAsGM1 antisera to deplete NK cells and subsequently treated with poly I:C/CCl 4 . Flow cytometric analysis confirmed a nearly complete depletion of hepatic NK cells in the antiAsGM1-treated mice (Fig. 4A) . As shown in Fig. 4B , representative BrdU incorporation of hepatocyte DNA synthesis showed that depletion of NK cells promoted the capacity of liver regeneration both in poly I:C/CCl 4 -coinjected or only CCl 4 -injected mice, especially in poly I:C/CCl 4 -coinjected mice. Summarized data in Fig. 4C showed that depletion of NK cells markedly increased the number of BrdU ϩ hepatocytes in poly I:C/CCl 4 group. In addition, we also depleted other cell types, such as Kupffer cells, CD4 ϩ T cells, and NK1.1 ϩ cells before poly I:C/CCl 4 injection, and found that only depletion of NK1.1 ϩ cells restored the full capacity of liver regeneration in poly I:C/CCl 4 -coinjected mice (Fig. 4D) . Additionally, depletion of NK cells before poly I:C/CCl 4 administration significantly prevented liver injury (Supplemental Fig. S2 ). Depletion of CD8 ϩ T cells had no effect on liver regeneration in mice treated with CCl 4 or poly I:C/CCl 4 (data not shown). These results suggest that NK cells contribute to poly I:C inhibition of liver regeneration in a model of CCl 4 -induced liver injury.
Poly I:C inhibits liver regeneration via an NK cell-derived TNF-␣ in a model of CCl 4 -induced injury.
To explore the mechanisms of the functional inhibitory molecule produced by the hepatic NK cells in liver regeneration in poly I:C/CCl 4 model, we examined the intracellular expression of TNF-␣ and IFN-␥ in NK cells. As shown in Fig. 5A , injection of poly I:C but not CCl 4 promoted significantly the production of TNF-␣ and IFN-␥ by hepatic NK cells 16 h postinjection. Poly I:C and CCl 4 cotreatment synergistically induced the production of these two cytokines. Consistent with these findings, poly I:C plus CCl 4 treatment significantly elevated serum levels of TNF-␣ and IFN-␥ at 12 h and 24 h, respectively, posttreatment (Fig. 5B) . These data suggest that NK cell-derived TNF-␣ and IFN-␥ may contribute to impaired liver regeneration in poly I:C/CCl 4 -treated mice. Therefore, to determine the role of TNF-␣ and IFN-␥ in impaired liver regeneration in poly I:C/CCl 4 -treated mice, mice were injected with anti-TNF-␣ or anti-IFN-␥ mAb neutralizing antibodies before poly I:C/CCl 4 treatment. As illustrated in Fig. 5 , C and D, neutralization of IFN-␥ exerted no significant effect on the liver regeneration, whereas neutralization of TNF-␣ significantly enhanced the capacity of liver regeneration in poly I:C/CCl 4 -treated mice (Fig. 5, C and D) . This indicates that NK cell-derived TNF-␣ is involved in the NK cell inhibition of liver regeneration in CCl 4 -treated mice.
DISCUSSION
Previous studies proposed that activated NK cells by poly I:C or MCMV infection are associated with impaired liver regeneration after partial hepatectomy (34) . During liver regeneration, hepatocytes and nonparenchymal cells rapidly undergo division while maintaining the functionality of the normal liver. This is achieved through the coordinated regulation of transcription factors, growth factors, cytokines, cell-cycleassociated proteins, signal transduction molecules, and a number of proteins of unknown functions (24) . Both partial hepatectomy and CCl 4 administration have been widely used as liver regeneration models; however, the mechanisms underlying liver regeneration in these two models may vary. Regeneration induced by partial hepatectomy occurs in the remnant liver with intact architecture, and, within several days, the liver can restore its mass and function. However, CCl 4 exposure is found to result in large areas of necrosis and cause a severe disruption in the structure of the liver. In this study, we examined whether the role of NK cells in the regulation of hepatic regenerative response after CCl 4 challenge was similar to the regenerative response after partial hepatectomy. Our results showed that activation of NK cells also inhibited liver regeneration in the CCl 4 model, which is similar to the NK cell-mediated inhibition of liver regeneration in the partial hepatectomy model (34) . However, NK cells inhibited liver regeneration in the CCl 4 model via a TNF-␣-dependent mechanism, which is different from the mechanism underlying NK cell inhibition of liver regeneration in the partial hepatectomy model that is dependent on IFN-␥ signaling pathway.
Previous studies have shown that injection of poly I:C inhibits liver regeneration in the partial hepatectomy model via activation of NK cells (34) . Here we have demonstrated that administration of poly I:C also induces NK cell activation, which contributes to poly I:C-mediated inhibition of liver regeneration. As shown in Fig. 2 , injection of CCl 4 alone significantly decreased the number of liver NKT cells but elevated liver NK cells, which is consistent with previous reports (28) . Injection of poly I:C, as expected, induced accumulation of NK cells in the liver. Interestingly, poly I:C and CCl 4 coinjection synergistically induced accumulation of NK cells in the liver. In addition, poly I:C and CCl 4 treatment also synergistically induced hepatic NK cell production of TNF-␣ and IFN-␥ and elevation of serum levels of these two cytokines (Fig. 5) . At the present, the mechanisms underlying the synergistic effect of poly I:C and CCl 4 are not clear and are presently under investigation in our laboratory. The findings that depletion of NK cells restored the full liver regeneration in poly I:C/CCl 4 cotreated mice suggest that NK cells contribute to poly I:C-mediated inhibition of liver regeneration in this CCl 4 model (Fig. 3) . Macrophages/Kupffer cells have been shown to inhibit liver regeneration (23, 37) and poly I:C is able to activate these cells; however, depletion of Kupffer cells did not enhance liver regeneration in poly I:C/CCl 4 -cotreated mice, suggesting that macrophages/Kupffer cells do not contribute to poly I:C inhibition of liver regeneration in this CCl 4 model. Finally, the role of NKT cells in poly I:C-mediated inhibition of liver regeneration remains unknown. Figure 4 shows that depletion of NK and NKT cells by anti-NK1.1 antibody resulted in a slightly higher number of BrdUϩ hepatocytes compared with depletion of NK cells alone by anti-AsGM1 antibody; however, depletion of NK cells alone restored almost complete liver regeneration in poly I:C/CCl 4 group. These findings suggest that activation of NK cells play a critical role, whereas NKT cells appear to play a less important role in poly I:C inhibition of liver regeneration induced by CCl 4 .
Another important finding in this paper is that NK cell production of TNF-␣, but not IFN-␥, plays an important role in poly I:C inhibition of liver regeneration in this CCl 4 model. It has been shown that NK cells inhibit liver regeneration via production of IFN-␥ in several models including partial hepatectomy and liver transplantation (8, 18, 33, 34, 36) . The inhibitory effect of IFN-␥ on liver regeneration is likely mediated via direct induction of hepatocyte cell cycle arrest and apoptosis through activation of STAT1 signaling pathway (36) . In the poly I:C/CCl 4 model we used in this study, the elevation of IFN-␥ secreted by NK cells was detected by intracellular staining, and serum levels of IFN-␥ were also markedly elevated (Fig. 4) ; however, neutralization of IFN-␥ did not restore liver regeneration in this model. This suggests that NK cells inhibit liver regeneration via an IFN-␥-independent mechanism. It is not clear why IFN-␥ produced by NK cells is involved in inhibition of liver regeneration in the partial hepatectomy model (34) but not in the CCl 4 model. It was reported that administration of CCl 4 causes hepatocyte production of reactive oxygen species that then in turn inhibit IFN-␥ activation of STAT1 in hepatic stellate cells (15) . Thus it is plausible to speculate that CCl 4 treatment induces hepatocytes to produce reactive oxygen species that also block IFN-␥ activation of STAT1 in hepatocytes, resulting in the insensitivity of hepatocytes to IFN-␥ inhibition of liver regeneration in the CCl 4 model. However, poly I:C activation of STAT1 in the liver was not suppressed in the mice after CCl 4 treatment (Supplemental Fig. S3 ), suggesting that a lack of inhibitory effect of poly I:C on liver regeneration in the CCl 4 model is not attributable to inhibition of STAT1 signaling.
In addition to elevation of IFN-␥, the plasma levels of TNF-␣ were also significantly elevated at 12 h in the poly I:C/CCl 4 -treated mice. TNF-␣ has been shown to play an important role in the initiation of liver regeneration through TNF-␣ receptor I under normal conditions after partial hepatectomy; however, TNF-␣ may also contribute to inhibition of liver regeneration after extensive hepatectomy (27, 39) . Here we showed that blockage of TNF-␣ restored the liver regeneration in the poly I:C/CCl 4 -treated mice, suggesting that upregulation of TNF-␣ contributes to poly I:C inhibition of liver regeneration in this CCl 4 model. At present, the mechanisms by which TNF-␣ inhibits liver regeneration remain unknown. It has been well documented that TNF-␣ not only plays an important role in initiation of normal hepatocyte proliferation during liver regeneration but also is the mediator of hepatotoxicity in many animal models (3, 31) . Thus it is likely that such high levels of TNF-␣ in poly I:C/CCl 4 model may contribute to significantly higher levels of liver injury (serum ALT) in these mice compared with CCl 4 alone group. Because clinical and animal studies have demonstrated that a threshold of 50% loss of hepatocytes in humans with acute liver failure and resections greater than standard 2/3 partial hepatectomy in rodents are associated with a significant decrease in proliferative activity of remaining hepatocytes (9, 16, 17) , it is reasonable to speculate that massive liver injury in poly I:C/CCl 4 may attribute to the reduced liver regeneration in this model. Further studies are needed to clarify this speculation.
In case of chemical toxin-induced liver injury, the liver initiates an immune response through proliferation of hepatocytes to restore liver function. If this process is inhibited, hepatic progenitor cells, also called oval cells, represent an important component of the regenerative response of the liver. They could proliferate and differentiate to hepatocytes, thus restoring liver mass. Hepatocyte proliferation plays a major role in restoration of centrilobular injury in the CCl 4 model; however, when hepatocyte proliferation is inhibited by treatment with N-2-acetylaminofluorene, restoration of necrotic area is accomplished by proliferation of ductal progenitor cells (4, 5, 45) . Thus it would be very interesting to test whether the proliferation of progenitor cells is increased in the poly I:C/ CCl 4 model in which hepatocyte proliferation is also suppressed. It has been reported that proliferation of hepatocytes and oval cells is controlled differentially by many cytokines, such as IFN-␥ and TNF-␣ (12, 25) . Several reports have shown that levels of IFN-␥ were elevated when oval cells proliferate, but were downregulated or remained unchanged during liver regeneration after partial hepatectomy, in which hepatocytes, but not oval cells, replicate (2, 19, 22) . Moreover, in mice deficient in IFN-␥, the oval cell response is attenuated, whereas hepatocyte replication in the regenerating liver is enhanced (1, 34) . As to TNF-␣, it was found that, lacking type I TNF receptor (TNFR-I), liver regeneration after partial hepatectomy was impaired, suggesting that TNF-␣, signaling through the TNFR-I, can initiate liver regeneration and act by activating an interleukin 6/STAT3-dependent pathway (44) . Meantime, oval cell proliferation was also inhibited in mice lack of TNFR-I fed a choline-deficient, ethionine-supplemented diet (19) . Taken together, both IFN-␥ and TNF-␣ promote oval cell proliferation. Because serum levels of IFN-␥ and TNF-␣ were markedly elevated after poly I:C/CCl 4 treatment and hepatocyte proliferation was suppressed, we speculate that the elevation of both cytokines likely stimulate oval cell proliferation in this model. Future studies are required to clarify this speculation. 
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